DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lastacaft (Alcaftadine) - News

 
 



News related to Lastacaft (Alcaftadine) and/or conditions it is approved for

Pinkeye (Conjunctivitis)
Source: MedicineNet Relapsing Polychondritis Specialty [2013.12.06]
Title: Pinkeye (Conjunctivitis)
Category: Symptoms and Signs
Created: 10/13/2003 12:00:00 AM
Last Editorial Review: 12/6/2013 12:00:00 AM

FDA OKs Sublingual Grastek for Timothy Grass Pollen Allergy
Source: Medscape Allergy & Clinical Immunology Headlines [2014.04.14]
The FDA approved a grass pollen allergen extract for the treatment of Timothy grass pollen-induced allergic rhinitis, with or without conjunctivitis, in individuals aged 5 to 65 years.
FDA Approvals

FDA approves first sublingual allergen extract for the treatment of certain grass pollen allergies
Source: Allergy News From Medical News Today [2014.04.04]
The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in...

Short course immunotherapy effective in reducing ragweed pollen allergy
Source: Allergy News From Medical News Today [2014.01.28]
Allergy Therapeutics, has announced that a paper entitled "Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen" is now available in...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012